Rx Drug Ads Should Not Characterize Probability Of Risk As Insignificant, FDA Emphasizes
Executive Summary
Agency’s final guidance on presenting quantitative efficacy and risk information in direct-to-consumer advertisements includes an additional example, which specifies risk should not be characterized in a way that suggests it is not important.